Fundz

Oxford Biotech Omass Therapeutics Raises £10M

PRIVATEMay 15, 2023

Amount Raised

£10 Million

Round Type

Funding Round

United StatesBiotechnology

Investors

Sanofi VenturesNorthpond VenturesGVOxford Science EnterprisesSynconaBritish Patient Capital

Description

Biotech startup OMass Therapeutics has raised £10m from British Patient Capital for its drug development platform.

Quick answer

OMass raised £10 Million in a Funding Round round, dated May 15, 2023. Investors: Sanofi Ventures, Northpond Ventures, GV, Oxford Science Enterprises, Syncona and British Patient Capital. OMass is based in United States.

How much did OMass raise?
OMass raised £10 Million in a Funding Round round on May 15, 2023.
Who invested in OMass?
Sanofi Ventures, Northpond Ventures, GV, Oxford Science Enterprises, Syncona and British Patient Capital are named as investors in this round.
What does OMass do?
It uses a combination of novel biochemistry, native mass spectrometry and custom chemistry.
Where is OMass based and how big is it?
OMass is based in United States. Fundz records about 11 employees.
Who are the decision-makers at OMass?
Fundz holds 2 contacts at OMass, including the CEO. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as OMass that raised within 45 days of this round, from Fundz verified event records.

  • CytomX Therapeutics, Inc. raised $30M on June 29, 2023.
  • CurvaFix raised $24M on June 29, 2023.
  • TearClear Corp. raised $12M on June 29, 2023.
  • Evommune raised an undisclosed amount (Series B) on June 28, 2023.
  • Gleamer SAS raised $30M (Funding Round) on June 28, 2023.
  • RiboPro raised an undisclosed amount (Funding Round) on June 28, 2023.

Who to call at OMass, and when

A new round usually means OMass is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day OMass raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at OMass, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at OMass. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

OMass

Location

United States

About

It uses a combination of novel biochemistry, native mass spectrometry and custom chemistry. The funding, which is an extension of its Series B, will be used for clinical development. OMass has also appointed Jim Geraghty, who sits on the boards of several US biotech firms, as its new chair.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment OMass raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsRos D., CEO hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for OMass's next move

See what Strategic adds

OMass raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.